Prostate Cancer

Principal Investigator:  Dr. J. Izawa
Hospital: London Health Sciences Centre - Victoria Hospital

  • A randomized, double-blind, placebo-controlled trial of Metformin in reducing progression among men on expectant management for low risk  prostate cancer
    • Study Coorinator: Jennifer Toopitsin  519.685.8500 ext 56366

Principal Investigator: Dr. J. Chin
Hospital: London Health Sciences Centre - Victoria Hospital
Localized Prostate Cancer - Pre-treatment:  

  • Anti-androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC).
    • Study Coorinator:  Wendy Shoff  519.685.8500 ext 57350
  • A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer who are Candidates for Radical Prostatectomy (PROTEUS).
    • Study Coordinator: Stephanie Horst 519.685.8500 ext 56601
  • Multi-Modality Prostate Cancer Image Guided Interventions 4: Pre-operative imaging with mpMRI, Sodium MRI and PSMA-PET prior to radical prostatectomy (IGPC-4).
    • Study Coordinator: Stephanie Horst 519.685.8500 ext 56601
Principal Investigator: Dr. J. Chin
Hospital: London Health Sciences Centre - Victoria Hospital
Prostate Cancer - Recurrent:
  • PSMA-PET Registry for Recurrent Prostate Cancer (PREP).
    • Study Coordinator: Stephanie Horst 519.685.8500 ext 56601
  • A Phase 3, Non-Randomized, Open Label, Multi-Centre Clinical Trial to Investigate the Safety and Efficacy of [18F]PSMA-1007 Injection in Men with Suspected Persistent or Recurrent Prostate Cancer (CPD-002).
    • Study Coordinator: Stephanie Horst 519.685.8500 ext 56601
  • A Multi-centre Clinical Study of the Sonablate(R)500 (SB-500) for the Treatment of Locally Recurrent Prostate Cancer with High Intensity Focused Ultrasound (HIFU).
    • Study Coordinator: Wendy Shoff 519.685.8500 ext 57350

Principal Investigator: Dr. J. Chin
Hospital: London Health Sciences Centre - Victoria Hospital
Prostate Cancer- Castration Resistant Non-metastatic:

  • A Multicentre Cohort Study of Patients with Advanced Prostate Cancer in Canada- observational cohorts for castration-resistant, non- metastatic prostate cancer (GURC Cohort Study).
    • Study Coordinator: Corrine Hickling 519.685.8500 ext 52619
Principal Investigator: Dr. J. Chin
Hospital: London Health Sciences Centre - Victoria Hospital

Prostate Cancer- Metastatic:

  • Phase 3 open-label Cabozantinib (XL184) in Combination with Atezolizumab vs Second novel Hormonal Therapy in subjects with High-Risk, Metastatic Castration-Resistant prostate Cancer (XL184-315).
    • Study Coordinator: Wendy Shoff  519.685.8500 ext 57350

Prostate Cancer - Other

  • The Role of Androgen Deprivation Therapy in Cardiovascular Disease – A Longitudinal Prostate Cancer Study (RADICAL PC1) and A Randomized Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (RADICAL PC2).
    • Study Coordinator: Corrine Hickling 519.685.8500 ext 52619